Elevance Health (ELV) Capital Expenditures (2010 - 2026)

Elevance Health (ELV) has 17 years of Capital Expenditures data on file, last reported at $287.0 million in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 7.49% year-over-year to $287.0 million in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 5.19% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 11.15% from the prior year.
• Capital Expenditures for Q2 2026 stood at $287.0 million, up from $235.0 million in the prior quarter.
• Over the last five years, Capital Expenditures for ELV reached as high as $360.0 million in Q3 2025 and fell as low as $196.0 million in Q1 2025.
• Historically, Capital Expenditures has averaged $296.8 million across 5 years, with a median of $299.5 million in 2022.
• Across the five-year window, Capital Expenditures grew 24.51% in 2022 and retreated 29.75% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $298.0 million in 2022, then increased by 9.4% to $326.0 million in 2023, then slipped by 1.23% to $322.0 million in 2024, then retreated by 9.01% to $293.0 million in 2025, then retreated by 2.05% to $287.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $287.0 million in Q2 2026, $235.0 million in Q1 2026, and $293.0 million in Q4 2025.